These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 31930541)
1. Betulinic acid restores imatinib sensitivity in BCR-ABL1 kinase-independent, imatinib-resistant chronic myeloid leukemia by increasing HDAC3 ubiquitination and degradation. Lu T; Wei D; Yu K; Ma D; Xiong J; Fang Q; Wang J Ann N Y Acad Sci; 2020 May; 1467(1):77-93. PubMed ID: 31930541 [TBL] [Abstract][Full Text] [Related]
2. Combination of panobinostat with ponatinib synergistically overcomes imatinib-resistant CML cells. Matsuda Y; Yamauchi T; Hosono N; Uzui K; Negoro E; Morinaga K; Nishi R; Yoshida A; Kimura S; Maekawa T; Ueda T Cancer Sci; 2016 Jul; 107(7):1029-38. PubMed ID: 27166836 [TBL] [Abstract][Full Text] [Related]
3. microRNA-199a/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells. Chen PH; Liu AJ; Ho KH; Chiu YT; Anne Lin ZH; Lee YT; Shih CM; Chen KC Chem Biol Interact; 2018 Aug; 291():144-151. PubMed ID: 29890129 [TBL] [Abstract][Full Text] [Related]
4. [Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro]. Wang XD; Qiu L; Lu RZ; Chen LJ; Zhan ZM; Han BH; Zhang BL; Ma J Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3399-405. PubMed ID: 18476538 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia. Chorzalska A; Ahsan N; Rao RSP; Roder K; Yu X; Morgan J; Tepper A; Hines S; Zhang P; Treaba DO; Zhao TC; Olszewski AJ; Reagan JL; Liang O; Gruppuso PA; Dubielecka PM Mol Oncol; 2018 May; 12(5):630-647. PubMed ID: 29485707 [TBL] [Abstract][Full Text] [Related]
6. Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-Abl. Lu Z; Jin Y; Chen C; Li J; Cao Q; Pan J Mol Cancer; 2010 May; 9():112. PubMed ID: 20482842 [TBL] [Abstract][Full Text] [Related]
7. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms. Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Carter BZ; Wang X; Shi X; Liu J J Hematol Oncol; 2016 Nov; 9(1):129. PubMed ID: 27884201 [TBL] [Abstract][Full Text] [Related]
8. Induction of heme oxygenase-1 by Na+-H+ exchanger 1 protein plays a crucial role in imatinib-resistant chronic myeloid leukemia cells. Ma D; Fang Q; Wang P; Gao R; Wu W; Lu T; Cao L; Hu X; Wang J J Biol Chem; 2015 May; 290(20):12558-71. PubMed ID: 25802333 [TBL] [Abstract][Full Text] [Related]
9. JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia. Aranda-Tavío H; Recio C; Martín-Acosta P; Guerra-Rodríguez M; Brito-Casillas Y; Blanco R; Junco V; León J; Montero JC; Gandullo-Sánchez L; McNaughton-Smith G; Zapata JM; Pandiella A; Amesty A; Estévez-Braun A; Fernández-Pérez L; Guerra B Biomed Pharmacother; 2021 Dec; 144():112330. PubMed ID: 34673425 [TBL] [Abstract][Full Text] [Related]
10. Heme oxygenase-1 reduces the sensitivity to imatinib through nonselective activation of histone deacetylases in chronic myeloid leukemia. Wei D; Lu T; Ma D; Yu K; Li X; Chen B; Xiong J; Zhang T; Wang J J Cell Physiol; 2019 Apr; 234(4):5252-5263. PubMed ID: 30256411 [TBL] [Abstract][Full Text] [Related]
11. Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells. Liu J; Zhang Y; Liu A; Wang J; Li L; Chen X; Gao X; Xue Y; Zhang X; Liu Y Int J Mol Sci; 2016 Apr; 17(4):531. PubMed ID: 27070592 [TBL] [Abstract][Full Text] [Related]
12. Small RNA activation of CDH13 expression overcome BCR-ABL1-independent imatinib-resistance and their signaling pathway studies in chronic myeloid leukemia. Su R; Wen Z; Zhan X; Long Y; Wang X; Li C; Su Y; Fei J Cell Death Dis; 2024 Aug; 15(8):615. PubMed ID: 39179585 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of Smad4 expression confers chemoresistance against imatinib mesylate to chronic myeloid leukemia K562 cells. Zhang J; Zhang M; Liang Y; Liu M; Huang Z Hematology; 2022 Dec; 27(1):43-52. PubMed ID: 34957936 [No Abstract] [Full Text] [Related]
14. S1P Signaling Genes as Prominent Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic Myeloid Leukemia. Morang S; Bisht M; Upadhyay V; Thapliyal S; Handu S OMICS; 2024 Jul; 28(7):367-376. PubMed ID: 38986084 [TBL] [Abstract][Full Text] [Related]
15. Platinum pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via DUB inhibition-dependent caspase activation and Bcr-Abl downregulation. Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Wang X; Shi X; Liu J Cell Death Dis; 2017 Jul; 8(7):e2913. PubMed ID: 28682311 [TBL] [Abstract][Full Text] [Related]
16. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia. Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353 [TBL] [Abstract][Full Text] [Related]
17. A novel tubulin polymerization inhibitor, MPT0B206, downregulates Bcr-Abl expression and induces apoptosis in imatinib-sensitive and imatinib-resistant CML cells. Chen CW; Lee YL; Liou JP; Liu YH; Liu CW; Chen TY; Huang HM Apoptosis; 2016 Sep; 21(9):1008-18. PubMed ID: 27344662 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes microenvironment-mediated imatinib resistance in chronic myeloid leukemia. Liu P; Ma D; Yu Z; Zhe N; Ren M; Wang P; Yu M; Huang J; Fang Q; Wang J Biomed Pharmacother; 2017 Jul; 91():21-30. PubMed ID: 28445830 [TBL] [Abstract][Full Text] [Related]
19. The First Pentacyclic Triterpenoid Gypsogenin Derivative Exhibiting Anti-ABL1 Kinase and Anti-chronic Myelogenous Leukemia Activities. Ciftci HI; Ozturk SE; Ali TFS; Radwan MO; Tateishi H; Koga R; Ocak Z; Can M; Otsuka M; Fujita M Biol Pharm Bull; 2018 Apr; 41(4):570-574. PubMed ID: 29386476 [TBL] [Abstract][Full Text] [Related]
20. Homoharringtonine suppresses imatinib resistance via the Bcl-6/p53 pathway in chronic myeloid leukemia cell lines. Wang Q; Ding W; Ding Y; Ma J; Qian Z; Shao J; Li Y Oncotarget; 2017 Jun; 8(23):37594-37604. PubMed ID: 28410239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]